Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-11-18
1993-08-17
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
052369323
ABSTRACT:
A method is provided for treatment of Parkinson's disease or controlling movement of a Parkinsonian patient by administering an ATP-sensitive potassium channel blocker, such as a sulfonyl urea, (for example, tolbutamide), or quinine.
REFERENCES:
patent: 4336259 (1982-06-01), Hadley
patent: 4812447 (1989-03-01), Roberts
Hansen et al, Dan. Med. Bull 12(7): 181-194 (Dec. 1965).
Gates et al, J.A.M.A. 1960: 172:1351-1354.
Gillhespy et al, Brit. Med. J. 1960: 2:1597.
Noma A. (1983), "ATP-regulated K.sup.+ channels in cardiac muscle," Nature 305: 147-148.
Kakei M. and Noma A. (1984) "Adenosine 5'-triphosphate-sensitive single potassium channel in the atrioventricular node cell of the rabbit heart," J. Physiol. 352: 265-284.
Ashcrfot, F. M. et al (1984), "Glucose induced closure of single potassium channels in isolated rat pancreatic .beta.-cells," Nature 312: 446-448.
Sturgess, N. C. et al (1985), "The sulphonylurea receptor may be an ATP-sensitive potassium channel," Lancent 8435: 474-475.
Standen, N. B. et al (1989), "Hyperpolarizing vasodilators activate ATP-sensitive K.sup.+ channels in arterial smooth muscle," Science 245: 177-180.
Mourre, C. et al (9189), "Antidiabetic sulfonylureas: localization of binding sites in the brain and effects on the hyperpolarization induced by anoxia in hippocampal slices," Brain Res. 486: 159-164.
Virsolvyl-Vergine, A. et al (1988), "An endogenous ligand for the central sulfonylurea receptor," FEBS Letters 242: 65-69.
Ungerstedt, U. (1971), "Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour," Acta Physiol. Scand. Suppl. 367: 49-68.
Greenfield, S. A. et al (1984), "A noncholinergic function for acetylcholinesterase in the substantia nigra:behavioural evidence," Expt. Brain Res. 54: 513-520.
Greenfield Susan A.
Levesque Denyse
E. R. Squibb & Sons Inc.
Hook Gregory
Rodney Burton
Waddell Frederick E.
LandOfFree
Method for treating Parkinson's disease employing quinine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating Parkinson's disease employing quinine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating Parkinson's disease employing quinine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2243922